Companies/US/KMTS

KESTRA MEDICAL TECHNOLOGIES, LTD.

Ownership & governance

Proxy officers8

NameRoleSinceShares
Al FordDirector or executive officer—167,295
Conor HanleyDirector or executive officer2025-01-0113,121
Elizabeth Kwo, M.DDirector or executive officer—10,909
Jeffrey SchwartzDirector or executive officer—10,909
Kevin ReillyDirector or executive officer2025-01-018,300
Raymond W. CohenDirector or executive officer2025-01-0150,903
Traci S. UmbergerDirector or executive officer—645,658
Vaseem MahboobDirector or executive officer—178,145

Filing shareholders6

NameOwnershipShares
Affiliate of Bain Capital43.00%25,172,338
T. Rowe Price Associates, Inc10.20%5,968,664
FMR LLC8.90%5,225,988
Affiliates of Endeavour Entities4.20%2,448,942
Brian Webster3.30%1,965,098

Proxy · as of 2026-09-09

Institutional (13F)

Loading Form 13F holders…

Fund membership

Loading fund baskets…

Street consensus

Consensus strong buyMean target 30.29Range 28–32Analysts 7
28Mean 30.2932
  • Strong buy 2
  • Buy 5
  • Hold 1

Broker actions20

FirmActionToTargetDate
BTIGReiteratedBuy322026-09-15
BTIGReiteratedBuy322026-09-02
JP MorganInitiatedOverweight302026-08-10
OppenheimerInitiatedPerform—2026-07-21
BTIGMaintainedBuy322026-07-15
Goldman SachsMaintainedNeutral172026-04-09
BTIGReiteratedBuy322026-04-07
BTIGReiteratedBuy322026-03-25
BTIGReiteratedBuy322026-03-18
Goldman SachsMaintainedNeutral252025-12-15
Wells FargoMaintainedOverweight282025-12-12
Piper SandlerMaintainedOverweight302025-12-12

Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.

Peers